Navigation Links
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Date:11/5/2011

ts and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTSAll statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated;
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
2. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
3. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
4. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
5. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
6. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
7. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
9. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
10. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
11. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... /PRNewswire-iReach/ -- United Medical Education, a company that provides ... Advanced Life Support (PALS) and Basic Life Support (BLS), ... online course manuals. In order to gain access ... an account with the company. By offering the free ... Education is setting a precedent among similar companies. ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will ... Ken Berger , CEO, and Ed Borkowski ... ET live via telephone. To participate in the conference ... 366-0267. To participate in the conference call outside the U.S. ... The conference ID is 72195398. Participants should dial in 10 ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... ... activity -, - ... patients -, SAN DIEGO, June 25 Ardea Biosciences, Inc.,(Nasdaq: ... 2a proof-of-concept monotherapy study of RDEA806, its novel,investigational non-nucleoside reverse transcriptase ...
... DIEGO, June 25 Mpex Pharmaceuticals, Inc. today,announced ... study with MP-376 for,the treatment of pulmonary infections ... with cystic fibrosis. MP-376 is Mpex,s,proprietary aerosol formulation ... key bacterial pathogens, including Pseudomonas,aeruginosa. Delivery of levofloxacin ...
Cached Medicine Technology:Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 2Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 3Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 4Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients 2Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients 3
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... Minor fender benders and serious car accidents ... to the accident to respond appropriately to the situation. ... (CDC) data from 2010, accidents, including car accidents, are ... fact, in 2005, automobile accident-related deaths cost ... 2.3 million drivers and passengers receive treatment in an ...
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
(Date:5/18/2013)... May 19, 2013 In “Cooking with Spirits ... iUniverse) , author Janet Hall Svisdahl’s new cookbook, readers are ... sure to make even the pickiest eater drool. “I dedicate ... prayerfully,” she explains. , Found within the 364 pages ... range of delicious recipes, from fast and simple to gourmet. ...
(Date:5/18/2013)... Society for Gastrointestinal Endoscopy (ASGE) will honor important contributions ... ASGE Crystal Awards on Sunday, May 19, 2013. Hosted ... will begin at 6:30 p.m. ... conjunction with Digestive Disease Week (DDW), the ASGE Crystal ... pursuit. The event will recognize the 2013 award and ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7
... limited pressure to achieve the ,thin and beautiful, ideal have ... study looking at five factors that may help young women ... of a society where discontent with appearance is common among ... of Arizona in the US, and colleagues is published online ...
... stimulating immune cells to more effectively battle cancerous tumors, ... effect, driving these intracellular fighters to exhaustion, a Mayo ... Journal of Clinical Investigation . The ... testing the treatment,s ability to ramp up the body,s ...
... News) -- Children who wake up at night and are allowed ... to be overweight than kids put back into their own bed, ... children aged 2 to 6 who had an increased risk of ... were overweight before becoming pregnant or their mothers were poor. ...
... News) -- Everyone knows teen behavior is highly influenced by their ... influence whether or not a teen drinks alcohol or uses drugs. ... their child,s drug or alcohol use, or worse, condone it, that ... study found. "Among friendship groups with ,good parents, there,s a ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) -- Women who ... to worry about gaining weight after the device is implanted, new ... aged 15 to 44 who were using two different types of ... About half of the women had a non-hormonal IUD containing copper ...
... A Wayne State University researcher believes a better ... one day help at-risk adolescents transition more quickly to ... To further that understanding, Tim Bogg, Ph.D., assistant ... and Sciences, has received a three-year, $731,000 grant from ...
Cached Medicine News:Health News:Self-worth needs to go beyond appearance 2Health News:Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment 2Health News:Study: Kids Who Sleep in Parents' Bed Less Likely to Be Overweight 2Health News:Friends' Parents Can Sway Teens' Odds for Drinking, Smoking 2Health News:IUD Use Tied to Modest Weight Loss 2Health News:IUD Use Tied to Modest Weight Loss 3Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 2Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: